Applications Open for Cancer Care Informatics Master’s - King Hussein Cancer Foundation and Center

Transforming Childhood Cancer Care in Peru - ACT 4 Children

Grand Rounds by OncoDaily: AI in Oncology Edition

How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Oncology News, Insights, Stories by OncoDaily

World Melanoma Day
Not To Miss

World Melanoma Day Global Symposium: Key Highlights From a Global Melanoma Discussion

OncoDaily at ASCO 2026
OncoDaily Pulse

OncoDaily at ASCO 2026

Roche
Oncology Tech

Roche and PathAI strike AI diagnostics deal worth up to $1B

Anthony Letai: Serendipitous Find Could Close A Pancreatic And Other Cancer Escape Route

Alireza Mansouri: Major Breakthrough in Male-Bias in Glioblastoma Biology

INAVO120: Inavolisib Benefit Persisted With or Without Hyperglycemia in PIK3CA-Mutated Advanced Breast Cancer

TAPUR Study: Nivolumab Plus Ipilimumab in High TMB Solid Tumors

10 Must-Read Posts In GU Oncology This Week

IGCS Introduces Candidates for Vice President in the 2026 Board of Directors Election

Advocacy Without Borders: Linking Policy, Practice, and Global Oncology

Voices
Porscha Johnson Williams

Porscha Johnson Williams: Evaluating Germline PGx Variants Alongside Somatic Mutations

Melvin L.K. Chua: 10 Day Road Trip across Europe Devoted to Nasopharyngeal Carcinoma

Roberta Ortiz: At Least 60% Survival and One Million Saved Lives by 2030

Wade Swenson: Rural Cancer Disparities are Fundamentally a Policy and Equity Problem

Alejandra Mendez: Moved by the Important Work Done with Childhood Cancer Survivors

Jan van de Winkel: Harnessing the Power of Antibodies to Transform Patients’ Lives

Amit Gupta: The Quiet, Extraordinary Power of Human Goodness

FDA Approvals
Daraxonrasib

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy

Resonance

15 May
Immunotherapy

NCCN 2026 Policy Summit: Innovations in Cancer Care Through the Ages

The National Comprehensive Cancer Network

25 Jun
NCCN

NCCN Global Policy Webinar - The Growing Cancer Burden in Young Adults

NCCN

21 May
NCCN

8th World Congress of the International Federation of Head and Neck Oncologic Societies (IFHNOS 2026)

International Federation of Head and Neck Oncologic Societies (IFHNOS)

26 Aug
IFHNOS

Global Cardio-Oncology Summit (GC-OS) 2026

International Cardio-Oncology Society (IC-OS)

05 Oct
Cardio-Oncology

Immune-oncology
TAPUR Study: Nivolumab Plus Ipilimumab in High TMB Solid Tumors

TAPUR Study: Nivolumab Plus Ipilimumab in High TMB Solid Tumors

NEOSUMMIT-01 Trial: Perioperative Toripalimab in Locally Advanced Gastric or Gastroesophageal Junction Cancer

RESET-C Trial: Single-Cycle Pembrolizumab in Localized dMMR Colon Cancer

Immunoradiotherapy With Nivolumab in High-Risk Prostate Cancer

NIVIPIT Trial: Can We Reduce Ipilimumab Toxicity Without Losing Efficacy?

Top Phase 3 Immunotherapy Trials at ASCO 2026

RESET-R Trial: One or Two Cycles of Nivolumab + Ipilimumab in dMMR Rectal Cancer

Gastrointestinal-Oncology
GI Oncology

10 Must-Read Posts In GI Oncology This Week

FDA Approved Zenocutuzumab-zbco for Advanced NRG1 Fusion-Positive Cholangiocarcinoma

Daraxonrasib Shows Antitumor Activity in Previously Treated RAS-Mutated Pancreatic Cancer

COLOSOTO Trial: Sotorasib + Panitumumab + 5-FU as 1L Therapy in KRAS G12C Mutated Colorectal Cancer

Top 10 Hepatobiliary Cancer Updates - April 2026

10 Must-Read Posts In GI Oncology This Week

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
INAVO120

INAVO120: Inavolisib Benefit Persisted With or Without Hyperglycemia in PIK3CA-Mutated Advanced Breast Cancer

ESMO Breast Cancer 2026: What You Should Not Miss

SATEEN Trial at ESMO Breast Cancer Annual Congress 2026: A Limited Activity of SG Plus Trastuzumab After T-DXd in HER2+ MBC

HER2CLIMB-02 Trial at ESMO Breast Cancer Annual Congress 2026: Tucatinib Plus T-DM1 Maintains PFS Benefit Without OS Improvement

SERENA-6 Trial at ESMO Breast Cancer Congress 2026: Ongoing ctDNA Monitoring for ESR1 Mutations in Advanced  Breast Cancer

SMART Trial at ESMO Breast Cancer Annual Congress 2026: ctDNA Tool Predicts Progression Risk in Metastatic Breast Cancer

CAPItello-291: Final OS Data Show No Significant Survival Benefit, but Capivasertib Plus Fulvestrant Extends Disease Control

Lung-Oncology
Older Adults

Nearly Half of Older Adults With Metastatic NSCLC Never Received Systemic Therapy

ZNF683+ CD8+ T Cells and SPP1 Signaling May Define Immunotherapy Response in NSCLC

Early Pembrolizumab Plasma Level May Predict Survival in Metastatic NSCLC

ICARUS-LUNG01 Reveals Biomarkers of Response and Resistance to Dato-DXd in Advanced NSCLC

MARIPOSA: Amivantamab Plus Lazertinib Reduces EGFR/MET Resistance and Extends Second-Line Disease Control in EGFR-Mutated NSCLC

FRONT-BRAF: Should Immunotherapy Come First in BRAF V600E-Mutated Metastatic NSCLC?

Pembrolizumab Injection: Powerful 1-Minute Shift in Lung Cancer Care

OncoDaily TV
Lucica Ditiu

Ending Tuberculosis by 2030: Is It Still Possible? | Dr Lucica Ditiu

City-Level Cancer Care: A Missing Piece in the Puzzle?

City-Level Cancer Care: A Missing Piece in the Puzzle?

Empowering Oncologists: Why Survivorship Matters?

Empowering Oncologists: Why Survivorship Matters?

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

European Conference on Interventional Oncology Jean Palussière

Highlights from The European Conference on Interventional Oncology ECIO 2026

Journey from Botswana South Africa

A Journey from Botswana to the Frontlines of Global Health Leadership։ Shenaaz El Halabi

Giuseppe Caruso SGO 2026 Congress Highlights

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology – Key Takeaways with Giuseppe Caruso

RichardGoldberg

Miles to Go Before We Sleep — Dr. Richard Goldberg on Curing Colorectal Cancer

A new partnership to take cancer vaccines from research to care - with Karen Knudsen and Kristen Dahlgren

A new partnership to take cancer vaccines from research to care – with Karen Knudsen and Kristen Dahlgren

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Noetic Medicine: The Science Behind Healing Through Words

Noetic Medicine: The Science Behind Healing Through Words

Not To Miss
GI Oncology

10 Must-Read Posts In GI Oncology This Week

World Melanoma Day Global Symposium: Key Highlights From a Global Melanoma Discussion

20 Posts Not To Miss From ESMO Breast Cancer Congress 2026

World Ovarian Cancer Day 2026: Raising Awareness on May 8

15 Posts Not To Miss From ASBrS2026

10 Must-Read Posts In GI Oncology This Week

Lung Cancer Hope Month 2026: Celebrating Progress in Modern Oncology

OncoGrants
Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Pediatric Cancer Research Foundation (PCRF) — Emerging Investigator Fellowship Grant

Pediatric Cancer Research Foundation (PCRF) — Emerging Investigator Fellowship Grant

Alex's Lemonade Stand Foundation — 'A' Award Grant

Alex's Lemonade Stand Foundation — 'A' Award Grant

Alex's Lemonade Stand Foundation — R Accelerator Grant

Alex's Lemonade Stand Foundation — R Accelerator Grant

Alex's Lemonade Stand Foundation — Bio-Therapeutics Impact Grant

Alex's Lemonade Stand Foundation — Bio-Therapeutics Impact Grant

Cancer Research UK — Career Development Fellowship (Lung Cancer Priority Area)

Cancer Research UK — Career Development Fellowship (Lung Cancer Priority Area)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
CLL-RT

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

CancerWorld

Oncologists
Vincenza Conteduca

Vincenza Conteduca

Oncologists Location Foggia, Italy
Eric Bernicker

Eric Bernicker

Oncologists Location Denver, USA
Antonio Lázaro Sánchez

Antonio Lázaro Sánchez

Oncologists Location El Palmar, Spain
Dragana Stanić Tišma

Dragana Stanić Tišma

Oncologists Location Belgrade, Serbia
Natalia Baran

Natalia Baran

Oncologists Location Bern, Switzerland
Fatjona Kraja

Fatjona Kraja

Oncologists Location Tirana, Albania
Denis Leonardo Fontes Jardim

Denis Leonardo Fontes Jardim

Oncologists Location São Paulo, Brazil
Airazat Kazaryan

Airazat Kazaryan

Oncologists Location Grålum, Norway

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

PROOF 301

PROOF 301 Trial: Infigratinib vs Gemcitabine/Cisplatin in FGFR2-Rearranged Cholangiocarcinoma

OncoDaily Medical Journal

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research